Business Context and Reporting Period
This Form 8-K filing by India Globalization Capital, Inc. (noted as IGC Pharma, Inc. in metadata) covers the period ending October 28, 2011. The report details the final reconvening of the 2011 Annual Meeting of Shareholders, which had been adjourned and reconvened multiple times since August 25, 2011.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and shareholder voting results regarding a specific equity issuance.
Material Changes and Voting Results
The primary material event is the shareholder approval of Proposal 3: the issuance of up to 5,000,000 shares of common stock to the Steven M. Oliveira 1998 Charitable Remainder Unitrust. This issuance stems from a Note and Share Purchase Agreement dated March 24, 2011.
- Outstanding Shares: 20,960,433 shares as of the meeting.
- Final Voting Results (Oct 28, 2011): 10,542,279 votes for; 645,135 votes against.
- Approval Percentage: Approximately 50.30% of outstanding shares voted in favor, exceeding the required 50% threshold.
- Progression: Support increased from 31.57% at the initial August meeting to 47.6% in mid-October, finally crossing the approval threshold on October 28.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of general business risks. The sole contingency addressed was the requirement to obtain shareholder approval for the stock issuance, which has now been satisfied.
Investor Verification Checklist
- Verify the final share count and the exact number of shares to be issued under the Note and Share Purchase Agreement.
- Confirm the dilution impact of the 5,000,000 new shares on existing shareholders.
- Review the terms of the March 24, 2011 Note and Share Purchase Agreement to understand the consideration received by the Company.
- Check subsequent filings for the actual issuance date and registration of the new shares.